Colozo 145mcg Capsules

Description

Introduction Of Colozo 145mcg Capsule:

Colozo 145mcg Capsule is a prescription medicine belonging to the class of guanylate cyclase-C agonists. It is primarily used in the management of Irritable Bowel Syndrome with Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC). The medicine works by increasing fluid secretion in the intestines, which helps soften stools, ease bowel movements, and reduce abdominal discomfort such as bloating and pain.

This capsule is generally recommended for adults and should be taken exactly as prescribed by a healthcare professional. It is not habit-forming and provides relief by improving bowel function and promoting regularity, thereby enhancing overall digestive comfort and quality of life.

Uses Of Colozo 145mcg Capsule

• Irritable Bowel Syndrome with Constipation (IBS-C)
• Chronic Idiopathic Constipation (CIC)
• Improved Bowel Function
• Relief from Abdominal Symptoms

Benefits Of Colozo 145mcg Capsule

Relieves Constipation: Helps soften stools and makes bowel movements easier and more regular. Reduces Abdominal Pain & Bloating: Provides relief from discomfort, cramping, and bloating often associated with IBS-C and chronic constipation. Improves Digestive Comfort: By regulating bowel activity, it enhances overall gut function and reduces the feeling of heaviness. Enhances Quality of Life: Promotes predictable bowel movements, allowing patients to feel more comfortable and confident in their daily routine. Safe for Long-term Use (under medical supervision): Unlike some laxatives, it works in a targeted way on the intestines and does not cause dependency.

Mechanism Of Action Colozo 145mcg Capsule

Active Ingredient: Colozo 145mcg contains Linaclotide, a guanylate cyclase-C (GC-C) agonist.

Activation of GC-C Receptors:

After oral intake, Linaclotide binds to guanylate cyclase-C receptors located on the lining (epithelium) of the intestine.

Increase in cGMP Levels:

This binding stimulates the production of cyclic guanosine monophosphate (cGMP) inside the intestinal cells.

Enhanced Fluid Secretion:

cGMP activates the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel, leading to increased secretion of chloride and bicarbonate into the intestinal lumen.

This process pulls water into the intestine, softening the stools and promoting smoother bowel movements.

Pain Reduction:

cGMP also acts outside the cells (extracellularly) to reduce pain-signal transmission in the gut, thereby decreasing abdominal pain and discomfort associated with IBS-C.

Contact Us